PreveCeutical Medical Inc.
VANCOUVER, A1 · Founded 2014 · CIK 0001721349 · Biotech · Public
Preventive and curative therapeutic formulations and treatments
preveceutical.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $254K
- 4 Form D · Nov 2018
- 95 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $84,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $142,390 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $7,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $21,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1189 | Bridge Therapeutics, Inc. | — | $321K |
| 1190 | BioVaxys Technology Corp. | — | $301K |
| 1191 | Petri Bio LLC | — | $255K |
| 1192 | PreveCeutical Medical Inc. | — | $254K |
| 1193 | KELIOMICS, INC. | — | $250K |
| 1194 | ELF ZONE, INC. | — | — |
| 1195 | Tengen Biomedical Co | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Matthew ColturaDirector
- Nicole Goncalves-KrysinskiExecutive Officer
- Makarand JawadekarDirector · Executive Officer
- Harendra ParekhExecutive Officer
- Shabira RajanDirector · Executive Officer
- Greg ReidDirector
- Kimberly Van DeventerDirector · Executive Officer · Promoter
- Stephen Van DeventerDirector · Executive Officer · Promoter
Patents
- Peptides And Uses Thereofapplication
- Peptides And Uses Thereofapplication
- Cyclic Peptides And Uses Thereofapplication
- Sol-gel Cannabinoid Formulation And Antiviral Useapplication
- Cannabinoid Formulations And Methods Of Useapplication
- A Cyclic Peptideapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.